Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Surveys and Questionnaires × Other × Clear all

Phase

Phase 2 4 Phase NA 3 Phase 3 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2 Thoracic 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Other 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Genitourinary 1 Breast 1

Conditions

Interventions

Radiotherapy 3 Cisplatin 2 glucarpidase 1 apraglutide 1 Therapeutics 1 Surveys and Questionnaires 1 Quercetin 1 Methotrexate 1 Leucovorin 1 Hydroxychloroquine 1 Fibroblast Growth Factor 7 1 Fentanyl 1 Curcumin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01515566 2014-08-22

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed

26 enrolled 7 charts

Dyspnea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡